1-20 of 103
Jose F. Leis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Patients with Small Lymphocytic Lymphoma (SLL) Receiving First Line Treatment

Samuel Kosydar, Kari G. Rabe, Yucai Wang, Saad S. Kenderian, Wei Ding, Eli Muchtar, Jose F. Leis, Amber Koehler, Mazie Tsang, Ricardo Parrondo, Talal Hilal, Rachel Bubik, Susan Marie Schwager, Curtis A. Hanson, Esteban Braggio, Susan L. Slager, Min Shi, Daniel L. Van Dyke, Timothy G. Call, Neil E. Kay, Sameer A. Parikh, Paul J Hampel
Journal: Blood
Blood (2023) 142 (Supplement 1): 3284.
https://doi.org/10.1182/blood-2023-181866
Published: 2023
Journal Articles

PD-1 Expression in Lymphoma Cells Mediates Cellular Proliferation By Engaging Phosphatase SHP-1/SHP-2

Sutapa Sinha, Tammy Price-Troska, Shulan Tian, R. Leo Sakemura, Huihuang Yan, Justin Boysen, Zhiquan Wang, Xiaosheng Wu, Rong He, Min Shi, Yucai Wang, Eric W Klee, Sameer A. Parikh, Paul J Hampel, Timothy G. Call, Jose F. Leis, Tait D. Shanafelt, Stephen M Ansell, Saad S. Kenderian, Neil E. Kay, Wei Ding
Journal: Blood
Blood (2023) 142 (Supplement 1): 3261.
https://doi.org/10.1182/blood-2023-177755
Published: 2023
Journal Articles

Incidence of Richter Transformation in Patients with Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL): A Cohort Study Evaluating Different Therapeutic Eras

Paul J. Hampel, Kari G. Rabe, Yucai Wang, Steven R Hwang, Saad S. Kenderian, Eli Muchtar, Jose F. Leis, Amber Koehler, Mazie Tsang, Ricardo Parrondo, Rachel Bubik, Susan Marie Schwager, Curtis A. Hanson, Esteban Braggio, Susan L. Slager, Min Shi, Daniel L. Van Dyke, Timothy G. Call, Neil E. Kay, Wei Ding, Sameer A. Parikh
Journal: Blood
Blood (2023) 142 (Supplement 1): 3271.
https://doi.org/10.1182/blood-2023-185076
Published: 2023
Journal Articles

Clinical Outcomes with Venetoclax-Based Treatment Regimens in Patients with Chronic Lymphocytic Leukemia (CLL)

Paul J. Hampel, Kari G. Rabe, Yucai Wang, Saad S. Kenderian, Wei Ding, Eli Muchtar, Jose F. Leis, Amber Koehler, Mazie Tsang, Ricardo Parrondo, Rachel Bubik, Susan Marie Schwager, Curtis A. Hanson, Esteban Braggio, Susan L. Slager, Min Shi, Daniel L. Van Dyke, Timothy G. Call, Neil E. Kay, Sameer A. Parikh
Journal: Blood
Blood (2023) 142 (Supplement 1): 3276.
https://doi.org/10.1182/blood-2023-183007
Published: 2023
Journal Articles

Association of Measurable Residual Disease with Progression-Free Survival in Patients with Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis in the Era of Novel Agents

Fausto Alfredo Alfredo Rios Olais, Alyssa K. McGary, Elena Juventina Tuna Aguilar, Diana Almader-Douglas, Mazie Tsang, Jose F. Leis, Matthew R. Buras, Talal Hilal
Journal: Blood
Blood (2023) 142 (Supplement 1): 1916.
https://doi.org/10.1182/blood-2023-190869
Published: 2023
Journal Articles

Low Incidence of Fungal Infections after Chimeric Antigen Receptor T-Cell Therapy for Non-Hodgkin Lymphoma in an Endemic Region for Coccidioidomycosis

Charles Gaulin, Matthew Ulrickson, Muhammad Husnain, Madiha Iqbal, Paschalis Vergidis, Allison C. Rosenthal, Hemant S. Murthy, Carolyn Mead-Harvey, Yucai Wang, Januario E. Castro, Jeanne M. Palmer, Jose F. Leis, Patrick B. Johnston, Janis E. Blair, Mohamed A. Kharfan-Dabaja, Yi Lin, Javier Munoz
Journal: Blood
Blood (2022) 140 (Supplement 1): 12111–12113.
https://doi.org/10.1182/blood-2022-159744
Published: 2022
Journal Articles

Treatment Patterns and Outcomes of Patients with Chronic Lymphocytic Leukemia with TP53 Mutations

Steven R Hwang, Yucai Wang, Kari G Rabe, Rong He, Saad S. Kenderian, Eli Muchtar, Paul J. Hampel, Neil E. Kay, Timothy G. Call, Amber Koehler, Amy L Behnken, Jose F. Leis, Esteban Braggio, Min Shi, David S. Viswanatha, Daniel L. Van Dyke, Susan L. Slager, Sameer A. Parikh, Wei Ding
Journal: Blood
Blood (2022) 140 (Supplement 1): 12390–12392.
https://doi.org/10.1182/blood-2022-165508
Published: 2022
Journal Articles

Comparison of Treatment-Emergent Adverse Events of Covalent BTK Inhibitors in Clinical Trials in B-Cell Malignancies: A Systematic Review and Meta-Analysis

Jacqueline F Wang, Steven R Hwang, Yi Jiang, Xinyue Qi, Shijia Zhang, Sameer A. Parikh, Wei Ding, Saad S. Kenderian, Eli Muchtar, Paul J. Hampel, Jose F. Leis, Javier L Munoz, Gita Thanarajasingam, Jonas Paludo, David J. Inwards, Grzegorz S. Nowakowski, Stephen M. Ansell, Thomas M. Habermann, Thomas E. Witzig, Neil E. Kay, Shouhao Zhou, Yucai Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 9882–9884.
https://doi.org/10.1182/blood-2022-168152
Published: 2022
Journal Articles

Quality of Control Arms in Randomized Trials of Chronic Lymphocytic Leukemia Enrolling in the USA: A Systematic Review

Adil Mohyudin, Diana Almader-Douglas, Jose F. Leis, Talal Hilal
Journal: Blood
Blood (2022) 140 (Supplement 1): 5050–5051.
https://doi.org/10.1182/blood-2022-168367
Published: 2022
Journal Articles

Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial

Clinical Trials & Observations
Tait D. Shanafelt, Xin Victoria Wang, Curtis A. Hanson, Elisabeth M. Paietta, Susan O’Brien, Jacqueline Barrientos, Diane F. Jelinek, Esteban Braggio, Jose F. Leis, Cong Christine Zhang, Steven E. Coutre, Paul M. Barr, Amanda F. Cashen, Anthony R. Mato, Avina K. Singh, Michael P. Mullane, Richard F. Little, Harry Erba, Richard M. Stone, Mark Litzow, Martin Tallman, Neil E. Kay
Journal: Blood
Blood (2022) 140 (2): 112–120.
https://doi.org/10.1182/blood.2021014960
Published: 2022
Includes: Supplemental data
Journal Articles

Higher Skeletal Muscle Index Is Associated with Improved Overall Survival in Older Patients with Sarcopenia Undergoing Allogeneic Stem Cell Transplant

Charles Gaulin, Blake T. Langlais, Luke Mountjoy, Panagiotis Korfiatis, Nelly Tan, Jose F. Leis, Nandita Khera, Pierre Noel, Lisa Z. Sproat, Tania Jain, Jeanne M. Palmer
Journal: Blood
Blood (2021) 138 (Supplement 1): 3960.
https://doi.org/10.1182/blood-2021-149274
Published: 2021
Journal Articles

Response to COVID-19 Vaccination Post-CAR T Therapy in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma

Julia E. Wiedmeier, Madiha Iqbal, Javier Munoz, Evandro D. Bezerra, Juan Esteban Garcia Robledo, Radhika Bansal, Patrick B. Johnston, Matthew Hathcock, Jeremy T. Larsen, P. Leif Bergsagel, Yucai Wang, Craig B. Reeder, Jose F. Leis, Rafael Fonseca, Jeanne M. Palmer, Rahma M Warsame, Taxiarchis Kourelis, Suzanne R. Hayman, David Dingli, Prashant Kapoor, Shaji Kumar, Urshila Durani, Jose C. Villasboas, Jonas Paludo, N. Nora Bennani, Stephen M. Ansell, Januario E Castro, Mohamed A. Kharfan-Dabaja, Yi Lin, Paschalis Vergidis, Hemant S. Murthy, Allison C. Rosenthal
Journal: Blood
Blood (2021) 138 (Supplement 1): 1750.
https://doi.org/10.1182/blood-2021-151859
Published: 2021
Journal Articles

Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL) Treated with the Combination of Ibrutinib (I) and Venetoclax (V; I+V) after Progression on I Alone (V-naïve) or after Progression on Sequential I and V (Double-Refractory)

Paul J. Hampel, Kari G. Rabe, Timothy G. Call, Wei Ding, Jose F. Leis, Asher Chanan-Khan, Saad S. Kenderian, Eli Muchtar, Yucai Wang, Sikander Ailawadhi, Amber Koehler, Susan M. Schwager, Taimur Sher, Curtis A. Hanson, Min Shi, Daniel L. Van Dyke, Esteban Braggio, Susan L. Slager, Neil E. Kay, Sameer A. Parikh
Journal: Blood
Blood (2021) 138 (Supplement 1): 1560.
https://doi.org/10.1182/blood-2021-151668
Published: 2021
Journal Articles

Quality of Life in Patients <=70 Years of Age with Chronic Lymphocytic Leukemia Treated Frontline with Ibrutinib-Rituximab Versus Fludarabine Cyclophosphamide Rituximab: Analysis from ECOG-ACRIN E1912

Priyanka A Pophali, Xin Victoria Wang, Fengmin Zhao, Neil E. Kay, Curtis A. Hanson, Mary L. Thomas, Susan M. O'Brien, Jacqueline Barrientos, Elisabeth M. Paietta, Jose F. Leis, Cong Christine Zhang, Steven Coutre, Paul M. Barr, Amanda Cashen, Anthony R. Mato, Avina Singh, Richard F. Little, Harry P. Erba, Richard M. Stone, Mark R. Litzow, Martin S. Tallman, Tait Shanafelt, Lynne I. Wagner
Journal: Blood
Blood (2021) 138 (Supplement 1): 1562.
https://doi.org/10.1182/blood-2021-150462
Published: 2021
Journal Articles

The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL

CME Clinical Trials & Observations
Sameer A. Parikh, Kari G. Rabe, Neil E. Kay, Timothy G. Call, Wei Ding, Jose F. Leis, Saad S. Kenderian, Eli Muchtar, Yucai Wang, Amber B. Koehler, Susan M. Schwager, Connie E. Lesnick, Geffen Kleinstern, Daniel Van Dyke, Curtis A. Hanson, Esteban Braggio, Susan L. Slager, Tait D. Shanafelt
Journal: Blood
Blood (2021) 138 (2): 149–159.
https://doi.org/10.1182/blood.2020009813
Published: 2021
Includes: Supplemental data
Journal Articles

Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families

CME Clinical Trials & Observations
Susan L. Slager, Mark C. Lanasa, Gerald E. Marti, Sara J. Achenbach, Nicola J. Camp, Fatima Abbasi, Neil E. Kay, Celine M. Vachon, James R. Cerhan, James B. Johnston, Timothy G. Call, Kari G. Rabe, Geffen Kleinstern, Nicholas J. Boddicker, Aaron D. Norman, Sameer A. Parikh, Jose F. Leis, Versha Banerji, Danielle M. Brander, Martha Glenn, Alessandra Ferrajoli, Karen Curtin, Esteban Braggio, Tait D. Shanafelt, Mary L. McMaster, J. Brice Weinberg, Curtis A. Hanson, Neil E. Caporaso
Journal: Blood
Blood (2021) 137 (15): 2046–2056.
https://doi.org/10.1182/blood.2020006322
Published: 2021
Includes: Supplemental data
Journal Articles

Identification of a Novel Role for PD-1 Signaling in Promotion Tumor Proliferation in B-Cell Lymphoma

Sutapa Sinha, PhD, Wei Ding, MD PhD, Tammy Price-Troska, BS, Reona Sakemura, MDPhD, Shulan Tian, MS, PhD, Charla R. Secreto, Xiaosheng Wu, MD, Timothy G. Call, MD, Rong He, MD, Sameer A. Parikh, MD, Yucai Wang, MDPhD, Jose F. Leis, MD PhD, Huihuang Yan, PhD, Karen Rech, MD, Amber B. Koehler, PA-C, MS, Daniel L. Van Dyke, PhD, Minetta C. Liu, MD, Susan L. Slager, PhD, Esteban Braggio, PhD, Stephen M. Ansell, MD PhD, Saad S. Kenderian, MB, ChB, Neil E. Kay, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–12.
https://doi.org/10.1182/blood-2020-136550
Published: 2020
Journal Articles

Genomic Profiling Reveals Molecular Heterogeneity in Patients with Richter's Syndrome (RS) and Progressive Chronic Lymphocytic Leukemia (CLL)

Shulan Tian, MS, PhD, Hanyin Wang, MD, Timothy G. Call, MD, Eric W. Klee, PhD, Minetta C. Liu, MD, Erik Jessen, PhD, Sameer A. Parikh, MD, Yucai Wang, MDPhD, Saad S. Kenderian, MB, ChB, Jose F. Leis, MD PhD, Min Shi, MDPhD, Eli Muchtar, MD, Daniel L. Van Dyke, PhD, Amber B. Koehler, PA-C, MS, Neil E. Kay, MD, Susan L. Slager, PhD, Esteban Braggio, PhD, Huihuang Yan, PhD, Wei Ding, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 16–17.
https://doi.org/10.1182/blood-2020-138397
Published: 2020
Journal Articles

Venetoclax Has Modest Efficacy in the Treatment of Patients with Relapsed T-Cell Prolymphocytic Leukemia

Paul J. Hampel, MD, Sameer A. Parikh, MD, Timothy G. Call, MD, Mithun Vinod Shah, MD PhD, Nabila Bennani, MD, Aref Al-Kali, MD, Kari G Rabe, Yucai Wang, MDPhD, Eli Muchtar, MD, Jose F. Leis, MD PhD, Saad S. Kenderian, MB, ChB, Amber B. Koehler, PA-C, MS, Susan M. Schwager, Daniel L. Van Dyke, PhD, Susan L. Slager, PhD, Neil E. Kay, MD, Min Shi, MDPhD, Wei Ding, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
https://doi.org/10.1182/blood-2020-134586
Published: 2020
Journal Articles

Adverse Events in Clinical Trials of Ibrutinib and Acalabrutinib for B-Cell Lymphoproliferative Disorders: A Systematic Review and Network Meta-Analysis

Talal Hilal, MD, William B Hillegass, MD PhD, Miguel Gonzalez-Velez, MD, Jose F. Leis, MD PhD, Allison C. Rosenthal, D.O.
Journal: Blood
Blood (2020) 136 (Supplement 1): 23.
https://doi.org/10.1182/blood-2020-137062
Published: 2020